This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Medimmune Limited. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Gene Colice: Innovator in Dermatological Treatments
Introduction
Gene Colice is a prominent inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of dermatology, particularly in the treatment of atopic dermatitis. His innovative approach has led to the development of methods that utilize interleukin-13 (IL-13) binding proteins for therapeutic purposes.
Latest Patents
Gene Colice holds 1 patent for his invention titled "Methods for treating atopic dermatitis and related disorders." This patent focuses on utilizing an anti-IL-13 antibody or an IL-13-binding fragment to treat atopic dermatitis and related disorders effectively.
Career Highlights
Colice is associated with MedImmune Limited, a leading biotechnology company. His work at MedImmune has allowed him to explore and develop groundbreaking treatments that address significant medical needs in dermatology.
Collaborations
Throughout his career, Gene has collaborated with notable professionals in the field, including Rene Van Der Merwe and Paul Baverel. These collaborations have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Gene Colice's innovative work in treating atopic dermatitis showcases his dedication to improving patient outcomes through scientific advancements. His contributions to the field are invaluable and highlight the importance of continued research in dermatological treatments.